In Kaiser Permanente’s integrated care delivery system, lung cancer patients benefit from care pathways, genetic sequencing of tumors, and cutting-edge research.
Enabled by virtual visits, case conferences and treatment tools, the COVID-19 pandemic has sped up the digital transformation of cancer care at Kaiser Permanente.
This year’s flu season arrives with the backdrop of a pandemic, prompting physicians and health officials to get creative in promoting flu shots and finding safe ways to deliver the vaccine, according to a recently published Washington Post story.
As the senior director of research for Kaiser Permanente in Southern California, Steven Jacobsen, MD, PhD, leads dedicated scientists and clinicians who use information collected during doctor and hospital visits to determine what really works — and what doesn’t work — in health care.
Stephen Parodi, MD, associate executive director, The Permanente Medical Group, and executive vice president, The Permanente Federation, recently highlighted the value of Kaiser Permanente’s integrated care system for cancer patients as part of the Self-Insurance Institute of America’s 39th annual Nation Educational Conference & Expo in San Francisco.
A Kaiser Permanente study finds 10-year follow-up interval after negative colonoscopies is associated with reduced risk of colorectal cancer and mortality.